We Focus on Identifying, Acquiring and Developing Disease-Modifying Therapeutic Drug Candidates with Rare Disease Indications
Location: United States, Florida, Boca Raton
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | Centrecour... | centrecour... |
Mentions in press and media 9
| Date | Title | Description |
| 12.10.2021 | CURATIVE BIOTECHNOLOGY : ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO | Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients, Late-Stage Rabies Therapeutic and Age-related Macular Degeneration Boca Raton, FL, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc.... |
| 07.10.2021 | Curative Biotechnology : Announces IMT504 License For Development Of Proprietary Next-Gen COVID-19 Vaccine | BOCA RATON, Fla., Oct. 7, 2021 /PRNewswire/ -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative Biotech" or the "Company") announced today that the Company has reached agreement with Mid-Atlantic BioTherapeutics (MABT... |
| 07.10.2021 | CURATIVE BIOTECHNOLOGY : ANNOUNCES IMT504 LICENSE FOR DEVELOPMENT OF PROPRIETARY NEXT-GEN COVID-19 VACCINE | License from Mid-Atlantic BioTherapeutics for IMT504 Broadens Scope of Initial License Beyond Treatment of Symptomatic Rabies Boca Raton, FL, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or ... |
| 02.09.2021 | Curative Biotechnology : Announces Addition of Dr. Nicholas Boulis to Scientific and Clinical Advisory Board | Company's Clinical Program for CD56 Monoclonal Antibody Drug Conjugate for Treatment of Glioblastoma to Benefit from Expertise in Neurobiology Boca Raton, FL, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT), anno... |
| 29.04.2021 | Curative Biotechnology, Inc. Announces FINRA Ticker Symbol Change From "CTYX" To "CUBT" | |
| 29.04.2021 | CONNECTYX TECH Curative Biotechnology : Inc. Announces FINRA Ticker Symbol Change From "CTYX" To "CUBT" | BOCA RATON, Fla., April 29, 2021 /PRNewswire/ -- Curative Biotechnology, Inc. (OTC: CUBT) a development stage biomedical company focused on novel therapies for rare diseases, announced today the Company's trading symbol change from "CT... |
| 09.03.2021 | CURATIVE BIOTECHNOLOGY, INC. Connectyx Reports Fiscal Year 2020 Financial Results | Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company... |
| - | Curative Biotechnology | “Curative Biotechnology - Novel Solutions for Unmet Medical Needs” |
| - | Connectyx Reports Fiscal Year 2020 Financial Results | Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company... |